Thomas Gerardus Hendrik Kempen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas Gerardus Hendrik Kempen has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Ulrika Gillespie
Department of Pharmacy Uppsala University Uppsala Sweden
9 shared publications- Derek Stewart
College of Pharmacy, QU Health, Qatar University, Doha, Qatar
5 shared publications - Ulrika Gillespie
Department of Pharmacy Uppsala University Uppsala Sweden
5 shared publications Henk-Frans Kwint
SIR Institute for Pharmacy Practice and Policy , Leiden
4 shared publicationsHåkan Melhus
Department of Medical Sciences Uppsala University Uppsala Sweden
4 shared publicationsLiset van Dijk
Nivel, Netherlands Institute for Health Services Research , Utrecht
4 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (5) , 1-13
Access to clinical data for direct oral anticoagulant prescriptions in community pharmacy and implications for medication optimisation: a mixed-methods study
Introduction: Inappropriate direct oral anticoagulant (DOAC) prescribing is a frequent cause of harm to patients. Pharmacists could play an important role in optimising prescribing, but they need access to relevant clinical data to do so. Little is known about community pharmacists’ access to clinical data to assess the appropriateness of DOAC prescriptions. Aim: To investigate the availability of relevant clinical data for DOAC prescriptions and whether additionally requesting such data supports community pharmacists in assessing and optimising DOAC prescriptions. This study also explored behavioural factors influencing pharmacists’ decisions to request additional clinical data. Method: In this mixed-methods study, 166 community pharmacies were approached to collect quantitative data. This included the prevalence of missing clinical data, pharmacists’ requests for missing data including reasons for requesting these data, and prescription adjustments made by the pharmacist. Missing clinical data was defined as absence of patient information on the DOAC prescription to assess its appropriateness: treatment indication, renal function, body weight, treatment duration, or concomitant use of antithrombotics. A random sample of 10 participating pharmacies was approached for semi-structured interviews on perceptions whether to request missing clinical data. Quantitative data were analysed descriptively. Interviews were thematically analysed using the Capability, Opportunity, Motivation, Behaviour (COM-B) framework to understand behaviour. Quantitative and qualitative data were triangulated through discussion of the findings. Results: We collected quantitative data of 583 DOAC prescriptions in 92 pharmacies and interviewed 11 pharmacists from 10 approached pharmacies. On 92.8% (n = 541) of DOAC prescriptions clinical data were missing. Additional clinical data (particularly, treatment indication and renal function) were requested in 51.9% (n = 281), mainly for dose evaluation (39.6% (n = 231)), leading to 5.0% (n = 14) adjustments of these prescriptions. Pharmacists applied clinical reasoning to determine the need for additional data, with providing optimal patient care as their primary motivation. The main opportunity was collaboration with other healthcare professionals. Conclusion: Using their clinical reasoning competence, pharmacists frequently requested missing clinical data, particularly treatment indication and renal function, to verify DOAC prescriptions and to ensure optimal patient care. Clinical data sharing could be optimised by streamlined collaboration between healthcare professionals.
- 22 May 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (5) , 1-13
Open AccessAccess to clinical data for direct oral anticoagulant prescriptions in community pharmacy and implications for medication optimisation: a mixed-methods study
Introduction: Inappropriate direct oral anticoagulant (DOAC) prescribing is a frequent cause of harm to patients. Pharmacists could play an important role in optimising prescribing, but they need access to relevant clinical data to do so. Little is known about community pharmacists’ access to clinical data to assess the appropriateness of DOAC prescriptions. Aim: To investigate the availability of relevant clinical data for DOAC prescriptions and whether additionally requesting such data supports community pharmacists in assessing and optimising DOAC prescriptions. This study also explored behavioural factors influencing pharmacists’ decisions to request additional clinical data. Method: In this mixed-methods study, 166 community pharmacies were approached to collect quantitative data. This included the prevalence of missing clinical data, pharmacists’ requests for missing data including reasons for requesting these data, and prescription adjustments made by the pharmacist. Missing clinical data was defined as absence of patient information on the DOAC prescription to assess its appropriateness: treatment indication, renal function, body weight, treatment duration, or concomitant use of antithrombotics. A random sample of 10 participating pharmacies was approached for semi-structured interviews on perceptions whether to request missing clinical data. Quantitative data were analysed descriptively. Interviews were thematically analysed using the Capability, Opportunity, Motivation, Behaviour (COM-B) framework to understand behaviour. Quantitative and qualitative data were triangulated through discussion of the findings. Results: We collected quantitative data of 583 DOAC prescriptions in 92 pharmacies and interviewed 11 pharmacists from 10 approached pharmacies. On 92.8% (n = 541) of DOAC prescriptions clinical data were missing. Additional clinical data (particularly, treatment indication and renal function) were requested in 51.9% (n = 281), mainly for dose evaluation (39.6% (n = 231)), leading to 5.0% (n = 14) adjustments of these prescriptions. Pharmacists applied clinical reasoning to determine the need for additional data, with providing optimal patient care as their primary motivation. The main opportunity was collaboration with other healthcare professionals. Conclusion: Using their clinical reasoning competence, pharmacists frequently requested missing clinical data, particularly treatment indication and renal function, to verify DOAC prescriptions and to ensure optimal patient care. Clinical data sharing could be optimised by streamlined collaboration between healthcare professionals.
- Open Access
- 20 April 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Integration of pharmacy practice research in the Dutch pharmacy education continuum
Pharmacy practice research is vital for evidence-based pharmaceutical care. Despite broad recognition of its value, it is unclear how pharmacy practice research skills should systematically be addressed in pharmacy education. This paper elaborates on how research is embedded in undergraduate, graduate, and postgraduate pharmacy education in the Netherlands and how this is put into pharmacy practice, and provides recommendations for further development of pharmacy practice research education. Utrecht University is taken as an example for undergraduate and graduate pharmacy education in the Netherlands. The bachelor’s phase provides a strong scientific foundation and systematic training in research skills, while the master’s emphasizes clinical and practice-oriented learning. Pharmacy practice research assignments are embedded throughout master-level rotations in community and hospital pharmacies, engaging students and supervising pharmacists in real-world research. This model familiarizes future pharmacists early on by engaging with practice-based research questions, collecting and interpreting data, and reflecting on their implications. After graduation, research and quality improvement remain core components of postgraduate specialization for both community and hospital pharmacists, although time pressures and workload limit routine involvement in practice-based research. Strengthening national coordination of research priorities, systematically linking student projects to high-quality practice research, and investing in doctor of philosophy pathways for community pharmacists could build sustainable research capacity. Together, these measures would more closely integrate education, research, and practice and thereby advance evidence-based pharmaceutical care in the Netherlands.
- 20 April 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Open AccessIntegration of pharmacy practice research in the Dutch pharmacy education continuum
Pharmacy practice research is vital for evidence-based pharmaceutical care. Despite broad recognition of its value, it is unclear how pharmacy practice research skills should systematically be addressed in pharmacy education. This paper elaborates on how research is embedded in undergraduate, graduate, and postgraduate pharmacy education in the Netherlands and how this is put into pharmacy practice, and provides recommendations for further development of pharmacy practice research education. Utrecht University is taken as an example for undergraduate and graduate pharmacy education in the Netherlands. The bachelor’s phase provides a strong scientific foundation and systematic training in research skills, while the master’s emphasizes clinical and practice-oriented learning. Pharmacy practice research assignments are embedded throughout master-level rotations in community and hospital pharmacies, engaging students and supervising pharmacists in real-world research. This model familiarizes future pharmacists early on by engaging with practice-based research questions, collecting and interpreting data, and reflecting on their implications. After graduation, research and quality improvement remain core components of postgraduate specialization for both community and hospital pharmacists, although time pressures and workload limit routine involvement in practice-based research. Strengthening national coordination of research priorities, systematically linking student projects to high-quality practice research, and investing in doctor of philosophy pathways for community pharmacists could build sustainable research capacity. Together, these measures would more closely integrate education, research, and practice and thereby advance evidence-based pharmaceutical care in the Netherlands.
- Open Access
- 6 March 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Prescription modifications by pharmacists and their views on potential prescribing authority: a nationwide survey
Objectives: In several countries, pharmacists have gained prescribing authority to enhance the quality and accessibility of healthcare. Elsewhere, pharmacists initiate or modify prescriptions that are subsequently countersigned by a prescriber, potentially serving as a stepping stone toward formal prescribing legislation. This study aimed to investigate current prescription modifications by Dutch pharmacists and their views on introducing prescribing authority. Methods: A nationwide cross-sectional survey was conducted among pharmacists in the Netherlands via national professional networks in April and May 2024. The questionnaire assessed current prescription modification practices, pharmacists’ agreement regarding the introduction of formal prescribing authority, and their perceived needs and readiness for prescribing. Data were analysed using descriptive statistics. Key findings: Among the 476 respondents, most worked in community pharmacy (76.7%; n = 365), followed by inpatient hospital pharmacy (14.7%; n = 70). The two most common prescription modifications were adjusting or initiating prescriptions based on clinical decision rules (81.1%; n = 386), and performing therapeutic substitution during drug shortages or according to local formularies (79.6%; n = 379). Almost all respondents favoured formal prescribing authority for at least one prescription modification practice (98.1%; n = 467). Respondents most often indicated clear task division and agreements between physicians and pharmacists (93.9%, n = 447) as a need for implementation. Readiness to use prescribing authority was reported by 92.6% (n = 441) of the respondents. Conclusions: The majority of pharmacists frequently initiate or modify prescriptions, and expressed both willingness and readiness to formalize these practices. These findings are valuable for policymakers considering the introduction of formal pharmacist prescribing authority.
- 6 March 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Open AccessPrescription modifications by pharmacists and their views on potential prescribing authority: a nationwide survey
Objectives: In several countries, pharmacists have gained prescribing authority to enhance the quality and accessibility of healthcare. Elsewhere, pharmacists initiate or modify prescriptions that are subsequently countersigned by a prescriber, potentially serving as a stepping stone toward formal prescribing legislation. This study aimed to investigate current prescription modifications by Dutch pharmacists and their views on introducing prescribing authority. Methods: A nationwide cross-sectional survey was conducted among pharmacists in the Netherlands via national professional networks in April and May 2024. The questionnaire assessed current prescription modification practices, pharmacists’ agreement regarding the introduction of formal prescribing authority, and their perceived needs and readiness for prescribing. Data were analysed using descriptive statistics. Key findings: Among the 476 respondents, most worked in community pharmacy (76.7%; n = 365), followed by inpatient hospital pharmacy (14.7%; n = 70). The two most common prescription modifications were adjusting or initiating prescriptions based on clinical decision rules (81.1%; n = 386), and performing therapeutic substitution during drug shortages or according to local formularies (79.6%; n = 379). Almost all respondents favoured formal prescribing authority for at least one prescription modification practice (98.1%; n = 467). Respondents most often indicated clear task division and agreements between physicians and pharmacists (93.9%, n = 447) as a need for implementation. Readiness to use prescribing authority was reported by 92.6% (n = 441) of the respondents. Conclusions: The majority of pharmacists frequently initiate or modify prescriptions, and expressed both willingness and readiness to formalize these practices. These findings are valuable for policymakers considering the introduction of formal pharmacist prescribing authority.
- Open Access
- 29 January 2026
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 18 (5) , 102589
Competencies needed for pharmacist prescribing: A qualitative study of competency frameworks to identify gaps in Dutch pharmacy education
- 29 January 2026
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 18 (5) , 102589
Open AccessCompetencies needed for pharmacist prescribing: A qualitative study of competency frameworks to identify gaps in Dutch pharmacy education
- Open Access
- 27 September 2025
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (2) , 501-512
Pharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study
Introduction: The role of pharmacists in healthcare has evolved, and in several countries, they have prescribing rights. Currently, pharmacists in Sweden do not have the right to prescribe. Exploring their views on pharmacist prescribing may be a critical step toward advancing the profession and improving patient care. Aim: To explore pharmacists’ views on potential pharmacist prescribing in Sweden. Method: An online questionnaire about pharmacist prescribing was distributed via email to Swedish pharmacists who are members of the Swedish Pharmacists Association (n = 5597). The questionnaire covered demographic information and statements about predefined prescribing models, preconditions, benefits, and risks associated with pharmacist prescribing. Each statement had a 4-point agreement Likert scale response option with additional “Don´t know/no opinion” option. Data were collected in May 2024. Closed-ended questions were analyzed descriptively, while open-ended questions were categorized and summarized. Results: Of the 395 respondents (7% response rate), 75.2% (n = 297) agreed with introducing at least one model of pharmacist prescribing. The two models that received the most support were “Prescribing based on an agreement or collaboration with one or more independent prescribers” (50.1%; n = 198) and “Independent, but limited prescribing rights” (48.1%; n = 190). All predefined preconditions were important for the respondents; their education (97.2%, n = 384) was identified as the most important factor. Overall, respondents agreed more with the benefits than the risks of introducing pharmacist prescribing. Most frequently (somewhat) agreeing that an enhanced professional position of pharmacists in health care was a key benefit (91.1%; n = 369), and the risks that respondents most (somewhat) agreed with included increased workload (80.8%; n = 319) and the conflict of interest involved in pharmacists acting as both prescribers and dispensers (60.8%; n = 240). Conclusion: The majority of respondents supported introducing at least one pharmacist prescribing model in Sweden. These findings provide valuable insights for policymakers considering an expanded role for pharmacists in Sweden, which may include a variety of extended professional roles in different settings.
- 27 September 2025
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (2) , 501-512
Open AccessPharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study
Introduction: The role of pharmacists in healthcare has evolved, and in several countries, they have prescribing rights. Currently, pharmacists in Sweden do not have the right to prescribe. Exploring their views on pharmacist prescribing may be a critical step toward advancing the profession and improving patient care. Aim: To explore pharmacists’ views on potential pharmacist prescribing in Sweden. Method: An online questionnaire about pharmacist prescribing was distributed via email to Swedish pharmacists who are members of the Swedish Pharmacists Association (n = 5597). The questionnaire covered demographic information and statements about predefined prescribing models, preconditions, benefits, and risks associated with pharmacist prescribing. Each statement had a 4-point agreement Likert scale response option with additional “Don´t know/no opinion” option. Data were collected in May 2024. Closed-ended questions were analyzed descriptively, while open-ended questions were categorized and summarized. Results: Of the 395 respondents (7% response rate), 75.2% (n = 297) agreed with introducing at least one model of pharmacist prescribing. The two models that received the most support were “Prescribing based on an agreement or collaboration with one or more independent prescribers” (50.1%; n = 198) and “Independent, but limited prescribing rights” (48.1%; n = 190). All predefined preconditions were important for the respondents; their education (97.2%, n = 384) was identified as the most important factor. Overall, respondents agreed more with the benefits than the risks of introducing pharmacist prescribing. Most frequently (somewhat) agreeing that an enhanced professional position of pharmacists in health care was a key benefit (91.1%; n = 369), and the risks that respondents most (somewhat) agreed with included increased workload (80.8%; n = 319) and the conflict of interest involved in pharmacists acting as both prescribers and dispensers (60.8%; n = 240). Conclusion: The majority of respondents supported introducing at least one pharmacist prescribing model in Sweden. These findings provide valuable insights for policymakers considering an expanded role for pharmacists in Sweden, which may include a variety of extended professional roles in different settings.
- Open Access
- 1 December 2024
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 47 (2) , 392-402
Pharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands
Background: Pharmacist prescribing legislation aims to enhance healthcare quality and accessibility. However, in many countries, like the Netherlands, it has not yet been legally established. Aim: To investigate pharmacists’ perspectives on potential pharmacist prescribing in the Netherlands. Method: An online survey using a questionnaire that was distributed via e-mail and electronic newsletters to most practicing pharmacists in the Netherlands during October and November 2023. The questionnaire was based on previous literature, further developed during an international conference with pharmacists and piloted with Dutch pharmacists. Agreement with statements about potential prescribing models, settings, preconditions, and perceived benefits and risks was measured using a 4-point Likert scale. Data were analysed descriptively. Results: In total, 625 participants from community pharmacy (n = 432; 69.1%), hospital pharmacy (n = 149; 23.8%), or other/combined settings (n = 44; 7.0%) completed the questionnaire. Most pharmacists (somewhat) agreed with the introduction of an independent prescribing model with limitations (n = 538; 86.1%) or a model dependent on collaborative agreements with physicians (n = 471; 75.4%). A minority (n = 245; 39.2%) supported independent prescribing with diagnostic authority. The precondition that participants most frequently (somewhat) agreed with was access to health records (n = 607; 97.1%). The most (somewhat) agreed-upon benefits were enhanced professional position of pharmacists (n = 574; 91.8%) and reduced workload for other prescribers (n = 573; 91.7%). Increased workload for pharmacists (n = 495; 79.2%) was the most (somewhat) agreed-upon identified risk. Conclusion: Pharmacists in the Netherlands are generally supportive of an independent but limited or collaborative pharmacist prescribing model. These findings support further investigations into the potential introduction of pharmacist prescribing legislation.
- 1 December 2024
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 47 (2) , 392-402
Open AccessPharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands
Background: Pharmacist prescribing legislation aims to enhance healthcare quality and accessibility. However, in many countries, like the Netherlands, it has not yet been legally established. Aim: To investigate pharmacists’ perspectives on potential pharmacist prescribing in the Netherlands. Method: An online survey using a questionnaire that was distributed via e-mail and electronic newsletters to most practicing pharmacists in the Netherlands during October and November 2023. The questionnaire was based on previous literature, further developed during an international conference with pharmacists and piloted with Dutch pharmacists. Agreement with statements about potential prescribing models, settings, preconditions, and perceived benefits and risks was measured using a 4-point Likert scale. Data were analysed descriptively. Results: In total, 625 participants from community pharmacy (n = 432; 69.1%), hospital pharmacy (n = 149; 23.8%), or other/combined settings (n = 44; 7.0%) completed the questionnaire. Most pharmacists (somewhat) agreed with the introduction of an independent prescribing model with limitations (n = 538; 86.1%) or a model dependent on collaborative agreements with physicians (n = 471; 75.4%). A minority (n = 245; 39.2%) supported independent prescribing with diagnostic authority. The precondition that participants most frequently (somewhat) agreed with was access to health records (n = 607; 97.1%). The most (somewhat) agreed-upon benefits were enhanced professional position of pharmacists (n = 574; 91.8%) and reduced workload for other prescribers (n = 573; 91.7%). Increased workload for pharmacists (n = 495; 79.2%) was the most (somewhat) agreed-upon identified risk. Conclusion: Pharmacists in the Netherlands are generally supportive of an independent but limited or collaborative pharmacist prescribing model. These findings support further investigations into the potential introduction of pharmacist prescribing legislation.
- Open Access
- 10 July 2024
- Published by Taylor & Francis in Journal of Interprofessional Care
- Vol. 38 (5) , 787-798
Pharmacists’ current and potential prescribing roles in primary care in the Netherlands: a case study
In some countries, pharmacists have obtained prescribing rights to improve quality and accessibility of care and reduce physician workload. This case study explored pharmacists' current roles in and potential for prescribing in primary care in the Netherlands, where prescribing rights for pharmacists do not exist. Participatory observations of pharmacists working in either general practice or community pharmacy were conducted, as were semi-structured interviews about current and potential practice. The latter were extended to patients and other healthcare professionals, mainly general practitioners, resulting in 34 interviews in total. Thematic analyses revealed that pharmacists, in all cases, wrote prescriptions that were then authorized by a physician before dispensing. General practice-based pharmacists often prescribed medications during patient consultations. Community pharmacists mainly influenced prescribing through (a) medication reviews where the physician and/or practice nurse often were consulted to make treatment decisions, and (b) collaborative agreements with physicians to start or substitute medications in specific situations. These findings imply that the pharmacists' current roles in prescribing in the Netherlands resemble collaborative prescribing practices in other countries. We also identified several issues that should be addressed before formally introducing pharmacist prescribing, such as definitions of tasks and responsibilities and prescribing-specific training for pharmacists.
- 10 July 2024
- Published by Taylor & Francis in Journal of Interprofessional Care
- Vol. 38 (5) , 787-798
Open AccessPharmacists’ current and potential prescribing roles in primary care in the Netherlands: a case study
In some countries, pharmacists have obtained prescribing rights to improve quality and accessibility of care and reduce physician workload. This case study explored pharmacists' current roles in and potential for prescribing in primary care in the Netherlands, where prescribing rights for pharmacists do not exist. Participatory observations of pharmacists working in either general practice or community pharmacy were conducted, as were semi-structured interviews about current and potential practice. The latter were extended to patients and other healthcare professionals, mainly general practitioners, resulting in 34 interviews in total. Thematic analyses revealed that pharmacists, in all cases, wrote prescriptions that were then authorized by a physician before dispensing. General practice-based pharmacists often prescribed medications during patient consultations. Community pharmacists mainly influenced prescribing through (a) medication reviews where the physician and/or practice nurse often were consulted to make treatment decisions, and (b) collaborative agreements with physicians to start or substitute medications in specific situations. These findings imply that the pharmacists' current roles in prescribing in the Netherlands resemble collaborative prescribing practices in other countries. We also identified several issues that should be addressed before formally introducing pharmacist prescribing, such as definitions of tasks and responsibilities and prescribing-specific training for pharmacists.
- Open Access
- 23 May 2024
- Published by Elsevier in Exploratory Research in Clinical and Social Pharmacy
- Vol. 14, 100453
Potential for pharmacist prescribing in primary care: A Dutch citizen perspective
- 23 May 2024
- Published by Elsevier in Exploratory Research in Clinical and Social Pharmacy
- Vol. 14, 100453
Open AccessPotential for pharmacist prescribing in primary care: A Dutch citizen perspective
- Open Access
- 12 August 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (6) , 1472-1482
Pharmacists in general practice: what do they do? A qualitative case study
Background: Pharmacists working in general practice are a relatively new phenomenon in many European countries. Providing insight into what pharmacists do in general practice may support further implementation of general practice-based pharmacist roles and enhance their contribution to health care. Aim: To explore the tasks performed by pharmacists in general practice in Sweden. Method: A case study was conducted in 7 general practices in Uppsala County, Sweden, where pharmacists were employed. Activities performed by pharmacists were self-reported during March 2021. Participant observations and semi-structured interviews with pharmacists were conducted between October and November 2021. Self-reported activities were categorised and analysed using descriptive statistics. Qualitative data were analysed using conventional content analysis. Results: In total, 174 activities were self-reported by 8 pharmacists. Two pharmacists were observed for 2 days each, and 6 pharmacists were interviewed. Their main task was conducting medication reviews in older patients with polypharmacy. In addition, they handled a broad variety of drug-related questions and treatment follow-up. Pharmacists described working in a more efficient and needs-based manner over time. They stressed that working at the practice increased their accessibility to and their collaborative work with other healthcare professionals, and enabled them to meet patients face-to-face. Future challenges include defining tasks more clearly, assuming greater responsibility for patient care, and meeting the growing demand for pharmacists in general practice. Conclusion: Pharmacists in general practice in Sweden perform a broad variety of tasks related to identifying, resolving and preventing drug-related problems, mainly in older patients with polypharmacy.
- 12 August 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (6) , 1472-1482
Open AccessPharmacists in general practice: what do they do? A qualitative case study
Background: Pharmacists working in general practice are a relatively new phenomenon in many European countries. Providing insight into what pharmacists do in general practice may support further implementation of general practice-based pharmacist roles and enhance their contribution to health care. Aim: To explore the tasks performed by pharmacists in general practice in Sweden. Method: A case study was conducted in 7 general practices in Uppsala County, Sweden, where pharmacists were employed. Activities performed by pharmacists were self-reported during March 2021. Participant observations and semi-structured interviews with pharmacists were conducted between October and November 2021. Self-reported activities were categorised and analysed using descriptive statistics. Qualitative data were analysed using conventional content analysis. Results: In total, 174 activities were self-reported by 8 pharmacists. Two pharmacists were observed for 2 days each, and 6 pharmacists were interviewed. Their main task was conducting medication reviews in older patients with polypharmacy. In addition, they handled a broad variety of drug-related questions and treatment follow-up. Pharmacists described working in a more efficient and needs-based manner over time. They stressed that working at the practice increased their accessibility to and their collaborative work with other healthcare professionals, and enabled them to meet patients face-to-face. Future challenges include defining tasks more clearly, assuming greater responsibility for patient care, and meeting the growing demand for pharmacists in general practice. Conclusion: Pharmacists in general practice in Sweden perform a broad variety of tasks related to identifying, resolving and preventing drug-related problems, mainly in older patients with polypharmacy.
- Open Access
- 30 May 2023
- Published by Springer Nature in Research Square
Pharmacists in general practice – What do they do? A qualitative case study
Background Pharmacists working in general practice are a relatively new phenomenon in many European countries. Providing insight into what pharmacists do in general practice may support further implementation of general practice-based pharmacists and their contribution to health care.Aim To explore the tasks performed by pharmacists in general practice in Sweden.Method A case study was conducted in 7 general practices in Region Uppsala, Sweden, where a pharmacist was employed. Activities other than medication reviews performed by pharmacists were self-reported during March 2021. Participant observations of and semi-structured interviews with pharmacists were conducted between October and November 2021. Self-reported activities were categorised and analysed using descriptive statistics. Qualitative data were analysed with conventional content analysis.Results In total, 174 activities were self-reported by 7 pharmacists. Two pharmacists were observed for 2 days each, and 6 pharmacists were interviewed. Their main task was conducting medication reviews in older patients with polypharmacy. In addition, they handled a broad variety of drug-related questions and treatment follow-up. Pharmacists described working in a more efficient and need-based manner over time. They stressed that working at the practice increased their accessibility for and to other healthcare professionals, and enabled them to meet patients face-to-face. Future challenges include defining tasks more clearly, assuming greater responsibility for patient care, and meeting the growing demand for pharmacists in general practice.Conclusion Pharmacists in general practice in Sweden perform a broad variety of tasks related to identifying, resolving and preventing drug-related problems, mainly in older patients with polypharmacy.
- 30 May 2023
- Published by Springer Nature in Research Square
Open AccessPharmacists in general practice – What do they do? A qualitative case study
Background Pharmacists working in general practice are a relatively new phenomenon in many European countries. Providing insight into what pharmacists do in general practice may support further implementation of general practice-based pharmacists and their contribution to health care.Aim To explore the tasks performed by pharmacists in general practice in Sweden.Method A case study was conducted in 7 general practices in Region Uppsala, Sweden, where a pharmacist was employed. Activities other than medication reviews performed by pharmacists were self-reported during March 2021. Participant observations of and semi-structured interviews with pharmacists were conducted between October and November 2021. Self-reported activities were categorised and analysed using descriptive statistics. Qualitative data were analysed with conventional content analysis.Results In total, 174 activities were self-reported by 7 pharmacists. Two pharmacists were observed for 2 days each, and 6 pharmacists were interviewed. Their main task was conducting medication reviews in older patients with polypharmacy. In addition, they handled a broad variety of drug-related questions and treatment follow-up. Pharmacists described working in a more efficient and need-based manner over time. They stressed that working at the practice increased their accessibility for and to other healthcare professionals, and enabled them to meet patients face-to-face. Future challenges include defining tasks more clearly, assuming greater responsibility for patient care, and meeting the growing demand for pharmacists in general practice.Conclusion Pharmacists in general practice in Sweden perform a broad variety of tasks related to identifying, resolving and preventing drug-related problems, mainly in older patients with polypharmacy.